Unichem Laboratories · NSE: UNICHEMLAB · BSE: 506690
Q2 FY25 results · Jul–Sep 2024
Unichem Laboratories reported revenue from operations of ₹462.16 crore (up 11.2% from Q2 FY24) and net profit of ₹30.49 crore for Q2 FY25 (Jul–Sep 2024), on a consolidated basis.
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 462.16 | 415.63 | +11.2% | 446.43 | +3.5% |
| Other income | 8.79 | 5.54 | +58.8% | 3.86 | +127.7% |
| Total income | 470.95 | 421.16 | +11.8% | 450.29 | +4.6% |
| Profit before tax | 32.99 | (21.88) | Turned profit | 15.00 | +120.0% |
| Net profit for the period | 30.49 | (24.49) | Turned profit | 9.26 | +229.4% |
| EPS, basic (₹) | 4.34 | (4.38) | Turned profit | 1.31 | +231.3% |
| Net margin (%) | 6.6 | -5.9 | 2.1 |
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 436.88 | 333.83 | +30.9% | 389.75 | +12.1% |
| Other income | 7.08 | 7.58 | −6.6% | 8.77 | −19.3% |
| Total income | 443.96 | 341.41 | +30.0% | 398.52 | +11.4% |
| Profit before tax | 43.37 | (30.81) | Turned profit | 21.48 | +101.9% |
| Net profit for the period | 43.37 | (30.81) | Turned profit | 21.48 | +101.9% |
| EPS, basic (₹) | 6.16 | (4.38) | Turned profit | 3.05 | +102.0% |
| Net margin (%) | 9.9 | -9.2 | 5.5 |
Consolidated
- Filed with BSE
- 13 Nov 2024, 15:02 IST
- Board meeting
- 13 Nov 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 Nov 2024, 15:02 IST
- Board meeting
- 13 Nov 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE